The Ventures Makes Seed Investment in 'LibraHealth', a Nutritional Supplement Brand for Female Athletes

The Ventures, a global venture capital (VC) firm specializing in early-stage investments, has made a seed investment in LibraHealth, a menstrual cycle-focused nutritional supplement brand exclusively for female athletes.

On August 20, a representative from The Ventures stated, "LibraHealth plans to use the funds for product development, certification, and the initial mass production. The company aims to begin a pilot supply to U.S. collegiate sports teams in the fourth quarter of this year and officially launch in the first quarter of next year."

Female athletes face challenges due to monthly fluctuations in physical condition associated with the menstrual cycle. According to a longitudinal study conducted by researchers at University College London (UCL), which tracked 26 elite players in England’s Women’s Super League (WSL) for three seasons, muscle injury risk was six times higher during the premenstrual phase than during menstruation, and five times higher during the early and mid-luteal phases. LibraHealth has moved beyond the limitations of existing products by adopting the menstrual cycle itself as a core design principle for their products.

LibraHealth CEO Yul Lee, a serial entrepreneur with over 15 years of experience in marketing and PR, has drawn upon personal experiences of battling cancer twice to research inflammation and hormonal health. LibraHealth’s debut product, "Golden," is named after the corpus luteum. To prevent doping risks, ingredients that directly affect hormones have been entirely excluded. The product especially leverages Korea’s traditional fermentation technology, combining kimchi-derived probiotics with plant-based ingredients, taking an approach centered on gut health and inflammation management.

The global women’s sports nutrition market is expected to grow from USD 23.8 billion (about KRW 33 trillion) this year to USD 55.4 billion (about KRW 77 trillion) by 2036. LibraHealth is entering the market not through large-scale marketing spending, but by building credibility among female athletes’ communities in U.S. collegiate and professional leagues. The company also plans to convert into a U.S. corporation within this year, and intends to broaden its customer base to include recreational female athletes in the future.

Cheolwoo Kim, CEO of The Ventures, said, "Although the women’s sports market is growing rapidly, there have been no nutritional supplements tailored to female physiology. We believe LibraHealth will become a market leader on the global stage, powered by Korea’s advanced fermentation technology."

CEO Lee stated, "We have approached the recurring discomforts experienced by female athletes from an inflammation management perspective. Our mission is to ensure that no athlete is ever unable to perform at their best because of natural body cycles."

This content was produced with the assistance of AI translation services.